Calcium Signaling Pathway Genes RUNX2 and CACNA1C Are Associated With Calcific Aortic Valve Disease

Background—Calcific aortic valve stenosis (AS) is a life-threatening disease with no medical therapy. The genetic architecture of AS remains elusive. This study combines genome-wide association studies, gene expression, and expression quantitative trait loci mapping in human valve tissues to identify susceptibility genes of AS. Methods and Results—A meta-analysis was performed combining the results of 2 genome-wide association studies in 474 and 486 cases from Quebec City (Canada) and Paris (France), respectively. Corresponding controls consisted of 2988 and 1864 individuals with European ancestry from the database of genotypes and phenotypes. mRNA expression levels were evaluated in 9 calcified and 8 normal aortic valves by RNA sequencing. The results were integrated with valve expression quantitative trait loci data obtained from 22 AS patients. Twenty-five single-nucleotide polymorphisms had P<5×10−6 in the genome-wide association studies meta-analysis. The calcium signaling pathway was the top gene set enriched for genes mapped to moderately AS-associated single-nucleotide polymorphisms. Genes in this pathway were found differentially expressed in valves with and without AS. Two single-nucleotide polymorphisms located in RUNX2 (runt-related transcription factor 2), encoding an osteogenic transcription factor, demonstrated some association with AS (genome-wide association studies P=5.33×10−5). The mRNA expression levels of RUNX2 were upregulated in calcified valves and associated with eQTL-SNPs. CACNA1C encoding a subunit of a voltage-dependent calcium channel was upregulated in calcified valves. The eQTL-SNP with the most significant association with AS located in CACNA1C was associated with higher expression of the gene. Conclusions—This integrative genomic study confirmed the role of RUNX2 as a potential driver of AS and identified a new AS susceptibility gene, CACNA1C, belonging to the calcium signaling pathway.

[1]  Y. Deshaies,et al.  Early Development of Calcific Aortic Valve Disease and Left Ventricular Hypertrophy in a Mouse Model of Combined Dyslipidemia and Type 2 Diabetes Mellitus , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[2]  C. Antzelevitch,et al.  A CACNA1C Variant Associated with Reduced Voltage-Dependent Inactivation, Increased CaV1.2 Channel Window Current, and Arrhythmogenesis , 2014, PloS one.

[3]  Y. Bossé,et al.  P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease. , 2014, Journal of molecular and cellular cardiology.

[4]  E. Ingelsson,et al.  Valvular osteoclasts in calcification and aortic valve stenosis severity. , 2013, International journal of cardiology.

[5]  M. Sandhu,et al.  Lipoprotein(a) levels, genotype and incident aortic stenosis: a prospective Mendelian randomization study and replication in a case-control cohort , 2013 .

[6]  Teri A. Manolio,et al.  Bringing genome-wide association findings into clinical use , 2013, Nature Reviews Genetics.

[7]  D. Towler.  Molecular and cellular aspects of calcific aortic valve disease. , 2013, Circulation research.

[8]  R. Goeree,et al.  Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update. , 2013, Ontario health technology assessment series.

[9]  Y. Bossé,et al.  NOTCH1 genetic variants in patients with tricuspid calcific aortic valve stenosis. , 2013, The Journal of heart valve disease.

[10]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[11]  David G Hendrickson,et al.  Differential analysis of gene regulation at transcript resolution with RNA-seq , 2012, Nature Biotechnology.

[12]  J. Ioannidis,et al.  What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. , 2012, International journal of epidemiology.

[13]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[14]  Y. Bossé,et al.  Replication of genetic association studies in aortic stenosis in adults. , 2011, The American journal of cardiology.

[15]  Giovanni Parmigiani,et al.  Integrating diverse genomic data using gene sets , 2011, Genome Biology.

[16]  Andrew D. Johnson,et al.  Association of Hypertension Drug Target Genes With Blood Pressure and Hypertension in 86 588 Individuals , 2011, Hypertension.

[17]  Michael Boehnke,et al.  LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..

[18]  P. Palade,et al.  Angiotensin II Upregulates CaV1.2 Protein Expression in Cultured Arteries via Endothelial H2O2 Production , 2010, Journal of Vascular Research.

[19]  Sangsoo Kim,et al.  GSA-SNP: a general approach for gene set analysis of polymorphisms , 2010, Nucleic Acids Res..

[20]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association , 2009, Circulation.

[21]  Davis J. McCarthy,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[22]  Muin J. Khoury,et al.  Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations , 2009, Bioinform..

[23]  Y. Bossé,et al.  Refining Molecular Pathways Leading to Calcific Aortic Valve Stenosis by Studying Gene Expression Profile of Normal and Calcified Stenotic Human Aortic Valves , 2009, Circulation. Cardiovascular genetics.

[24]  P. Deloukas,et al.  Common Regulatory Variation Impacts Gene Expression in a Cell Type–Dependent Manner , 2009, Science.

[25]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[26]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[27]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[28]  K. Sirotkin,et al.  The NCBI dbGaP database of genotypes and phenotypes , 2007, Nature Genetics.

[29]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[30]  R. Bonow,et al.  Calcific aortic stenosis: an update , 2007, Nature Clinical Practice Cardiovascular Medicine.

[31]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[32]  J. Gardin,et al.  Burden of valvular heart diseases: a population-based study , 2006, The Lancet.

[33]  V. Probst,et al.  Familial Aggregation of Calcific Aortic Valve Stenosis in the Western Part of France , 2006, Circulation.

[34]  D. Srivastava,et al.  Mutations in NOTCH1 cause aortic valve disease , 2005, Nature.

[35]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[36]  B. Horne,et al.  Evidence for a Heritable Component in Death Resulting From Aortic and Mitral Valve Diseases , 2004, Circulation.

[37]  M. Mäyränpää,et al.  Induction of local angiotensin II-producing systems in stenotic aortic valves. , 2004, Journal of the American College of Cardiology.

[38]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[39]  R. Lorentzon,et al.  Oestrogen receptor α gene polymorphism is related to aortic valve sclerosis in postmenopausal women , 2003, Journal of internal medicine.

[40]  C. Otto,et al.  Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma , 2002, Circulation.

[41]  C M Otto,et al.  Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. , 1997, Circulation.

[42]  R. Ophoff,et al.  University of Groningen Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression , 2017 .

[43]  B. Warren,et al.  Calcification of the aortic valve: Its progression and grading , 1997, Pathology.

[44]  Yun-Cai Liu,et al.  Association of the , 1995 .

[45]  P. Fleming,et al.  Aortic stenosis. , 1960, The Quarterly journal of medicine.

[46]  P. McKeigue,et al.  Problems of reporting genetic associations with complex outcomes , 2003, The Lancet.